Business Concept & Goals 
Business Concept
Tripep's business concept is to create a successful biotechnology company by developing and commercialising CDs either based on its patent-pending and patented technologies or by inlicensing CDs and technologies.
Goals
ChronVac-C®
Tripep's objective for the coming year for ChronVac-C® is to begin a phase I trial on healthy volunteers in early- 2007. The study will be conducted at Karolinska University Hospital in Solna, Sweden, with its results expected to be available in late-2007. If the results are positive, it will be followed by a phase II trial on hepatitis C patients.
ChronSeal
Tripep's objective for the coming year for the recently acquired wound-healing project ChronSeal is to formulate a development plan and begin development activities. The agreement with Kringle Pharma ensures Tripep access to HGF. Tripep will prioritize work on ensuring the production of ChronSeal and identifying a suitable type of preparation. Toxicology studies will begin as soon as this is achieved. In tandem with this process, the trial protocol will be designed and the necessary documentation compiled to gain a permit to start a phase II trial.